FDA Approves Abbott's Tecnis Toric Intraocular Lens

Abbott (Abbott Park, Il) received FDA approval for its Tecnis 1-Piece Toric Intraocular Lens. The lens is designed for cataract patients who suffer from corneal astigmatism.Astigmatism is caused when a patient's cornea does not have a normal curvature. This stops light rays from properly focusing on the back of a patient's eye. When light can't focus on the retinal cells in the back of the eye, vision can become distorted. With the Tecnis 1-Piece Toric Intraocular Lens, physicians can correct astigmatism of one diopter (a quantitative unit for the refractive power found in a lens) or more.The average cataract surgery patient in the United States is 68. Every year, approximately 3.5 million cataract surgeries are performed. For older patients, the Tecnis Toric 1-Piece Intraocular Lens maintains high stability. The device also minimizes imprecise light focusing, known as spherical aberration, to ensure that patients have sharper long-distance vision."The TECNIS Toric 1-Piece IOL represents the latest advancement in cataract technology and expands Abbott's portfolio of the TECNIS family of IOLs," noted Murthy Simhambhatla, senior VP of the medical optics division at Abbott. He continued, "The TECNIS Toric 1-Piece IOL allows surgeons to offer an additional lens option that provides proven visual outcomes to increase patient satisfaction."More news from Abbott:Abbott's Medical Device Division StrugglingFDA Panel Approves Abbott's MitraClip...ReservedlyAbbott Cuts 200 Jobs at Irish Manufacturing Facility